Can GLP-1 medications help when standard blood tests don’t yet show prediabetes?
Yes, they can, depending on the full picture of your health.
GLP-1 medications were first approved to treat diabetes, but they’re now also approved for obesity and weight management. They work by mimicking a natural hormone that helps regulate appetite, digestion, and blood sugar. Even if your blood sugar levels aren’t yet in the prediabetes range, GLP-1s can still improve insulin response, lower sugar production in the liver, and reduce visceral fat, which is the belly fat linked to insulin resistance and inflammation.
Here at Alloy, we look at more than just lab numbers. Newer guidelines make it clear that BMI alone isn’t enough, and the same goes for a single blood sugar test. Midlife hormonal shifts, body composition changes, and increasing visceral fat all matter. If you’re gaining weight despite healthy habits, especially in perimenopause or menopause, that metabolic shift can start before bloodwork crosses into prediabetes.
In this short clip, Dr. Mary Claire Haver talks about metabolic screening and how some patients who are prediabetic are good candidates for GLP-1s, and how these decisions are individualized: Personalizing Menopause Treatment | Dr. Mary Claire Haver - Metabolic Health and Screening
At Alloy, you don’t need bloodwork to get started. We base care on your medical history, symptoms, and risk factors, not just lab results. Our clinicians will review your full health profile to decide if a GLP-1 like Zepbound, Wegovy, or compounded liraglutide makes sense for you.
If you’d like to learn more about how these medications work, this overview is a helpful place to start: How GLP-1s Support Weight Loss & Metabolic Health And if you’re curious whether you qualify, you can explore our Weight Care program here: Weight Care program
This answer was created using the following resources: